Nasal Splints Market Report 2025

This Nasal Splints market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The nasal splints market size has grown strongly in recent years. It will grow from $6.73 billion in 2024 to $7.39 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to postoperative recovery, trauma and fractures, rhinoplasty procedures, improved patient comfort.

The nasal splints market size is expected to see strong growth in the next few years. It will grow to $10.42 billion in 2029 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to minimally invasive techniques, emerging markets growth, regulatory support, telehealth and remote consultation. Major trends in the forecast period include advanced materials, customized solutions, digital health integration, sustainable and eco-friendly practices.

The growing number of rhinoplasty surgeries is expected to drive the expansion of the nasal splints market in the coming years. Rhinoplasty is one of the most commonly performed reconstructive cosmetic surgeries worldwide. For example, according to Rhinoplasty London, an England-based rhinoplasty clinic, 82% of rhinoplasty surgeries in 2023 were performed on female patients, while males accounted for 18%. In comparison, 17.4% of rhinoplasty procedures in 2022 were conducted on male patients. Intranasal splints are commonly used as part of the post-operative procedure to promote hemostasis, provide structural support, and reduce scar formation. As a result, the increasing number of rhinoplasty surgeries is fueling the growth of the nasal splints market.

The growing demand for minimally invasive procedures is anticipated to be a driving force behind the expansion of the nasal splints market. Minimally invasive treatments entail medical interventions that aim to achieve therapeutic or diagnostic outcomes with minimal disruption to the body's tissues and structures. Nasal splints play a pivotal role in many minimally invasive nasal procedures. They assist in supporting nasal tissues, maintaining the desired shape of the nose or sinuses, and promoting healing. For example, in January 2023, reports from Intuitive Surgical Inc., a US-based manufacturer of robotic products, indicated that da Vinci procedures, a type of minimally invasive surgery, had increased by approximately 22% in 2023, with a projected further increase of 13% to 16% in 2024. In 2023, the company installed 1,370 da Vinci surgical systems, reflecting an 8% increase from the 1,264 systems installed in 2022. As a result, the growing demand for minimally invasive procedures is contributing to the growth of the nasal splints market.

Nasal splints constructed from biodegradable materials have been gaining traction in the industry due to their unique properties. These materials, which include plant-based and bioresorbable materials, aid in controlling bleeding after surgery or nasal trauma. They eliminate the need for the painful removal of nasal packing for patients and serve as an adjunct to assist in the natural healing process. For example, Smith & Nephew offers a dissolvable nasal splint called Nasastent, composed of plant-based carboxymethyl cellulose. This splint provides support to the soft nasal tissue, applies pressure to prevent bleeding, and ultimately transforms into a hydrocolloidal gel after absorbing nasal fluid, which drains naturally from the patient. Several other companies, such as Hemostasis LLC and Medtronic, also offer biodegradable nasal splints. As per the US FDA, nasal splints are classified as Class I medical devices exempted from premarket notification. However, nasal splint manufacturers are required to register their establishment and list the generic category or classification name.

Leading companies in the nasal splints market are innovating new products, such as external nasal splints, to improve patient outcomes and broaden their product portfolios. External nasal splints are supportive devices placed on the outside of the nose after surgical procedures like rhinoplasty (nose reshaping) or septoplasty (correction of a deviated septum). For example, in August 2023, Orfit Industries NV, a Belgium-based company specializing in thermoplastic materials for medical devices, launched NoseFit. NoseFit is an external nasal splint designed to provide optimal stabilization and protection for the nose following surgeries, sports injuries, or accidents. The splint features small holes that promote airflow, helping patients breathe more easily while wearing it.

Major companies operating in the nasal splints market include Boston Medical Products Inc., Innovia Medical, Medtronic PLC, Olympus Corporation, Smith & Nephew PLC, DTR Medical, Mentor Worldwide LLC, Network Medical Products Ltd., Summit Medical Group, Surgiform Technologies LLC, Shippert Medical Technologies, Spiggle & Theis Medizintechnik GmbH, Stryker Corporation, Acclarent Inc., Cook Medical, KARL STORZ SE & Co. KG, Integra LifeSciences, Medline Industries LP, B. Braun Melsungen AG, Merit Medical Systems, Intersect ENT, ArthroCare Corporation, Lumenis, ConMed Corporation, DePuy Synthes Companies, Zimmer Biomet, KLS Martin Group, Becton Dickinson and Company, Terumo Corporation, Johnson & Johnson, 3M, Teleflex Medical OEM.

Nasal splints are specialized devices created to offer support and stability after nasal surgery. Intranasal splints are inserted into the nasal passages to maintain septal stability and prevent the formation of intranasal adhesions after septal surgery. On the other hand, external nasal splints are applied to the outside of the nose to immobilize and protect it following rhinoplasty or nasal contouring procedures.

The key types of nasal splints on the market include malleable nasal splints, airway nasal splints, and bivalve nasal splints. Bivalve nasal splints are specifically designed to provide support to the septum and minimize or prevent adhesions between the septum and the lateral nasal wall that might occur post-surgery. Nasal splints find applications in various medical fields, such as plastic surgery, rhinological operations, and ear, nose, and throat (ENT) surgery. These devices are utilized by a variety of end-users, including hospitals, clinics, home care providers, and research centers.

The nasal splints market research report is one of a series of new reports that provides nasal splints market statistics, including nasal splints industry global market size, regional shares, competitors with a nasal splints market share, detailed nasal splints market segments, market trends and opportunities, and any further data you may need to thrive in the nasal splints industry. This nasal splints market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Asia-Pacific was the largest region in global nasal splints market in 2024. North America was the second-largest region in the nasal splints market. The regions covered in the nasal splints market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the nasal splints market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

The nasal splints market consists of sales of instruments such as malleable nasal splints, airway nasal splints, and bivalve nasal splints. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.